FIELD: medicine.
SUBSTANCE: lachrymal fluid and blood serum are examined by enzyme immunoassay using specific test systems. Higher levels of metalloproteinase-9 (MMP-9) exceeding 52.5 ng/ml in lachrymal fluid and 274.49 ng/ml in blood serum; higher levels of a complex of metalloproteinase-9 and its tissue inhibitor (MMP-9/TIMP-1) exceeding 0.19 ng/ml in lachrymal fluid and 4.93 ng/ml in blood serum, and higher levels of secretory immunoglobulin A (slgA) exceeding 47.38 mg/l in lachrymal fluid and 2.1 g/l in blood serum are the criteria to diagnose primary open-angle glaucoma.
EFFECT: use of the declared method can effectively diagnosing primary open-angle glaucoma.
6 dwg, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING RATE OF PROGRESSION OF GLAUCOMA OPTIC NEUROPATHY | 2017 |
|
RU2665005C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING INITIAL OPEN-ANGLE GLAUCOMA WITHOUT EXFOLIATION SYNDROME USING DATA ON POLYMORPHISM OF MATRIX METAL PROTEINASE GENES | 2021 |
|
RU2760958C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA WITH EXFOLIATIVE SYNDROME BASED ON MOLECULAR GENETIC DATA | 2021 |
|
RU2753268C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA IN WOMEN ACCORDING TO GENETIC DATA | 2021 |
|
RU2753270C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA WITHOUT EXFOLIATION SYNDROME | 2022 |
|
RU2790757C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA USING DATA ON CDKN2B-AS1 GENE POLYMORPHISM | 2021 |
|
RU2771137C1 |
| METHOD FOR PREDICTING THE RISK OF PRIMARY OPEN-ANGLE GLAUCOMA BASED ON THE DATA ON POLYMORPHIC VARIANTS OF THE LYSYL OXIDASE-LIKE ENZYME 1 GENE | 2021 |
|
RU2784769C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA WITH EXFOLIATIVE SYNDROME | 2021 |
|
RU2777667C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA IN MEN BASED ON GENETIC DATA | 2021 |
|
RU2775430C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA IN WOMEN | 2021 |
|
RU2775431C1 |
